DENYES NANCY (General Counsel) purchased 29.0% of their position (5K shares) of ATYR PHARMA INC on the open market
Open‑market purchase worth $9.3K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/6/2024ACC: 0000950170-24-069680
Officer· General Counsel
Since Feb 2019
+5K
Net shares
Net buyer
$9.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
5K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5K
Price / share
$1.86
Trade value
$9.28K
% of position
29.0%
6/5/2024
17.27K→22.27K
Total
Net shares
+5K
Net value
$9.28K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/5/2024 | P · Purchase | +5K | $1.86 | $9.28K | 29.0% | 17.27K | 22.27K |
| Total | +5K | $9.28K | ||||||
Derivative Transactions0
No derivative transactions reported